Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
FILANA THERAPEUTICS, INC.Filana Therapeutics Reports $90.9 Million Net Loss and Faces FDA Clinical Hold on Simufilam
RARE ELEMENT RESOURCES LTDRare Element Resources Reports $4.9 Million Net Loss for Fiscal Year 2025
VanEck Bitcoin ETFVanEck Bitcoin ETF Reports $1.38 Billion NAV with 7.95% Yearly Increase
SANTO MINING CORP.Groovy Company Reports No Revenue in Q3 2025, Net Loss Improves Amid Strategic Changes
IDT CORPIDT Corporation Reports 5.4% Revenue Growth to $320.5 Million in Q2 Fiscal 2026
INCOME OPPORTUNITY REALTY INVESTORS INC /TX/Income Opportunity Realty Investors Reports Decrease in Net Income and Revenue for Fiscal Year 2025
TRANSCONTINENTAL REALTY INVESTORS INCTranscontinental Realty Reports $14.4M Net Income for Fiscal Year 2025, Driven by Asset Sales
AMERICAN REALTY INVESTORS INCAmerican Realty Investors Reports $18.5 Million Net Income Turnaround for Fiscal Year 2025
Heritage Insurance Holdings, Inc.Heritage Insurance Holdings Reports $195.6 Million Net Income for Fiscal Year 2025
VITASPRING BIOMEDICAL CO. LTD.VitaSpring Biomedical Reports No Revenue and $1.1 Million Net Loss for Fiscal Year Ending January 31, 2024
CF BANKSHARES INC.CF Bankshares Inc. Reports $17.5 Million Net Income for Fiscal Year 2025
FIRST US BANCSHARES, INC.First US Bancshares Reports $5.99 Million Net Income for Fiscal Year 2025
Seres Therapeutics, Inc.Seres Therapeutics Reports $5.7M Net Income for 2025, Significant Recovery from Previous Year
BUTLER NATIONAL CORPButler National Corporation Reports 13% Revenue Growth and 78% Net Income Increase for Nine Months Ending January 31, 2026
Astrana Health, Inc.Astrana Health Reports $3.18 Billion Revenue for 2025, Driven by Acquisition and Capitation Growth
Theriva Biologics, Inc.Theriva Biologics Reports $23.7 Million Net Loss and Strategic License Agreement with Rasayana Therapeutics
Orchestra BioMed Holdings, Inc.Orchestra BioMed Reports $32.9M Partnership Revenue Surge and $52.7M Net Loss for 2025
reAlpha Tech Corp.reAlpha Tech Corp. Reports 376% Revenue Growth but Faces $17.59 Million Net Loss
Century Therapeutics, Inc.Century Therapeutics Reports $109.2M Collaboration Revenue and Strategic Pipeline Update in 10-K Filing
Candel Therapeutics, Inc.Candel Therapeutics Reports Financial Results and Operational Progress in 10-K Filing
MBX Biosciences, Inc.MBX Biosciences Reports $87M Net Loss and Business Update in Annual Filing
MAYS J W INCJ.W. Mays Reports Increased Net Loss and Decreased Revenues for Q1 2026
Sunrise Realty Trust, Inc.Sunrise Realty Trust Reports 143.2% Increase in Interest Income for Fiscal Year 2025
PRECISION BIOSCIENCES INCPrecision BioSciences Reports $34.3M Revenue Decline and $45.7M Net Loss in 2025
TIC Solutions, Inc.TIC Solutions Reports $1.53 Billion Revenue with 39.4% Growth, Net Loss of $87.1 Million